In HIV research, new types of reagents are needed to target infected cells and overcome HIV's ability to vary its HLA-I-restricted antigens and escape from host cytotoxic T lymphocytes. Here Varela-Rohena and colleagues use phage display technology to generate high-affinity T-cell antigen receptors that recognize common epitope-escape variants of the immunodominant HLA-A*02-restricted, HIVgag-specific peptide SLYNTVATL (SL9).
- Angel Varela-Rohena
- Peter E Molloy
- James L Riley